fda stance on compounded semaglutide Hims & Hers stock falls 25% as curtails GLP-1s FDA Ban on Compounded GLP-1
Description
Call it legal doping for the rest of us
However, researchers soon realised its potential therapeutic use in humans as an anticoagulant
Microscopic analysis revealed visible structural differences between groups
No forced titration
Surface engineering further enhances their targeting specificity
Overall, human interventions with prebiotics have shown mixed results, so further work is needed
